BPI-1178

· Beta Pharma (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BPI-1178, covering 2024-07-10 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer [Phase 1, Phase 2]